IMPLANON

This brand name is authorized in Austria, Australia, Brazil, Ecuador, Spain, Ireland, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa

Active ingredients

The drug IMPLANON contains one active pharmaceutical ingredient (API):

1 Etonogestrel UNII 304GTH6RNH - ETONOGESTREL

Etonogestrel is the biologically active metabolite of desogestrel, a progestagen widely used in OCs. It is structurally derived from 19-nortestosterone and binds with high affinity to progesterone receptors in the target organs. The contraceptive effect of etonogestrel is primarily achieved by inhibition of ovulation. Read about Etonogestrel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMPLANON NXT Implant for subdermal use	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AC08	Etonogestrel	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8487Q
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527301801154319, 527316110018803
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29951-07-11
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 62628
Country: IE	Health Products Regulatory Authority	Identifier(s): 28801, 28853
Country: MT	Medicines Authority	Identifier(s): MA031/01701, PI770/08302A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 321M2000
Country: NL	Z-Index G-Standaard	Identifier(s): 14266377
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 52353
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14189
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100149791
Country: SG	Health Sciences Authority	Identifier(s): 14086P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/18.8/0448